The invention relates to plasma or liver lipid species selected from the triacylglycerol (TAG) and cardiolipin (CL) lipid classes measured by LC-MS/MS and use thereof as diagnostic and prognostic biomarkers of fatty liver, as well as to monitor the efficacy of preventive and therapeutic measures to lower liver fat content.
Type
patent
EPO Family ID
58016549
Author(s)
Note
Alternative title(s) : (fr) Espèces lipidiques du plasma et du foie utilisées comme biomarqueurs du foie gras
TTO classification
TTO:6.1720
| Identifier | Country code | Kind code | Date issued |
US2020096524 | US | A1 | 2020-03-26 |
WO2018141965 | WO | A3 | 2018-10-25 |
WO2018141965 | WO | A2 | 2018-08-09 |
Available on Infoscience
December 5, 2019
Use this identifier to reference this record